Foundations Investment Advisors LLC Trims Holdings in Cigna Group $CI

Foundations Investment Advisors LLC decreased its stake in shares of Cigna Group (NYSE:CI) by 21.2% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 2,224 shares of the health services provider’s stock after selling 600 shares during the period. Foundations Investment Advisors LLC’s holdings in Cigna Group were worth $735,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Flaharty Asset Management LLC purchased a new stake in shares of Cigna Group in the first quarter worth about $28,000. 1248 Management LLC bought a new stake in Cigna Group during the 1st quarter worth approximately $29,000. Solstein Capital LLC bought a new stake in Cigna Group during the 2nd quarter worth approximately $29,000. Activest Wealth Management lifted its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new position in Cigna Group in the 2nd quarter valued at $30,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Stock Up 0.4%

CI opened at $272.50 on Wednesday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The business’s 50-day moving average price is $288.56 and its 200-day moving average price is $299.97. The company has a market cap of $72.79 billion, a P/E ratio of 14.87, a P/E/G ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the company earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is presently 26.64%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. decreased their price target on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a report on Tuesday, November 4th. Morgan Stanley restated an “overweight” rating and issued a $355.00 target price on shares of Cigna Group in a research note on Friday, October 31st. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Thursday, November 13th. Finally, Wells Fargo & Company lowered their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $334.05.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.